In our study, subjects with FLI ≥ 60 had a significantly higher frequency of previous cardiovascular disease and MetS as well as significantly increased plasma concentrations of triglycerides, alanine aminotransferase (ALT) and aspartate aminotransferase (AST), as compared to subjects without suspected NAFLD (FLI < 60). The gene discussed is GPT; the disease is metabolic syndrome.